Publications database

Partnership is a guiding principle for the EMCDDA as it works to increase its understanding of the external dimension of the drug phenomenon and its implications for public health and security in...

These are the EMCDDA's final annual accounts for the financial year 2017.

The General Report of Activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its...

This brochure provides an overview of the 2018 European Drug Report package and includes a brief summary of the main headlines.

For more than 20 years, the European information network on drugs and drug addiction (Reitox), has been the cornerstone of the European drug monitoring and reporting system, to which it contributes by...

The EMCDDA Programming Document for the period 2018–20 covers the final year of implementation of the EMCDDA Strategy 2016–18 and coincides with the completion of the first Roadmap established under the new...

For more than 20 years, the European information network on drugs and drug addiction (Reitox), has been the cornerstone of the European drug monitoring and reporting system, to which it contributes by...

For more than 20 years, the EU drugs agency (EMCDDA) has demonstrated its ability to act as a catalyst for data collection and strategic analysis in a policy area that cuts across...

In this issue: Lisbon Addictions 2017 | New EMCDDA guide on responses | EMCDDA responds to increasing risks posed by new fentanils | IPA5 project draws to a close | Supporting global...

The EMCDDA receives stable funding under Commission budget line B3-441 of the general budget of the European Union. Each year, a preliminary draft budget is presented by the Centre's Director to the...